This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nagai, H. Articles by Nagai, H. Search for Related Content PubMed PubMed Citation Articles by Nagai, H. Articles by Nagai, H. Social Bookmarking                         What's this?

Primary Antiphospholipid Syndrome and Pulmonary Hypertension with Prolonged Survival

A Case Report

Keiichi Yasuma, MD

Tatsuo Katsuki, MD

Atsuhiro Shimakura, MD

Kazuo Usuda, MD

Yukio Nakamura, MD

Shigeo Takata, MD

Ken-ichi Kobayashi, MD

Hideo Nagai, MD

First Department of Internal Medicine Kanazawa University 13-1 Takara-machi Kanazawa, 920, Japan

The outcome of patients with pulmonary hypertension (PHT) and antiphospholipid syndrome (APS) is usually fatal. The authors report the rare case of a patient with primary APS and nonthrombotic PHT who has survived for twenty years after the onset of PHT. In this case, the patient's PHT resembled the primary idiopathic variety with clear lung fields and normal perfusion on the lung scan, and the combination therapy with nitrate, digoxin, and diuretics had been performed. During her clinical course over twenty years, she had not experienced any critical pulmonary thrombosis that influenced the progression of nonthrombotic PHT or any other severe systemic involvement of APS.

Angiology, Vol. 48, No. 2, 183-187 (1997)
DOI: 10.1177/000331979704800213


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?